The University Teaching Hospital of Butare has acquired three advanced medical machines worth more than 12 billion Rwandan francs, a move expected to improve specialized care and significantly reduce patient referrals to Kigali, hospital officials said.
Rwanda is preparing to introduce a new and more comprehensive vaccine against the human papillomavirus (HPV), a major cause of cervical cancer, as part of its push to eliminate the disease by 2027, health officials said.
Rwanda has launched a trial of an artificial intelligence-powered application designed to help doctors diagnose patients faster and choose appropriate medications more quickly, officials said.
The Rwanda Biomedical Center has warned wetland farmers that working barefoot and without gloves puts them at high risk of contracting bilharzia, a parasitic disease that remains widespread in the country.
The use of family planning services in Rwanda continues to rise, driven largely by increased adoption of modern contraceptive methods, according to the latest annual report by the National Institute of Statistics of Rwanda.
Cervical cancer remains one of the leading health threats to women in Rwanda, second only to breast cancer, with more than 700 new cases recorded each year. The disease accounts for roughly one in six cancer-related deaths in the country, according to the Rwanda Biomedical Centre.
President Paul Kagame has reaffirmed Rwanda’s commitment to advancing Africa’s health sovereignty, emphasizing the importance of the African Medicines Agency (AMA) in strengthening the continent’s regulatory and pharmaceutical capacity.
Twenty women from Jabana Sector, Gasabo District, have completed a month-long training on preparing balanced diets — an initiative they say will help combat malnutrition and improve family health.
Rwanda is championing artificial intelligence (AI) as a key solution to Africa’s healthcare challenges, emphasizing its potential to improve access, speed, and quality of medical services across the continent.
